Being Tactical = Mo...
Health Care: Drugs
Amylin Pharmaceuticals Inc (AMLN: NASDAQ)
$17.05 0.58 | 3.52%
02/09/12 - 04:00 PM ET
5.45M / 2.11M
Vol / Avg. Vol:15.68 / 16.47
Open / Prev. Close:15.60 - 17.10
Today's Range:8.03 - 18.30
52 Wk Range:49.82%
Performance YTD:TheStreet Rating:
Portfolios with AMLN
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- UserBerliner
- Contributor13 Biotech Stocks Bought an...
- ContributorBreakout Stocks Of The Week...
- ProCarl Icahn
- ContributorBreakout Stocks Of The Week...
- UserLosers
- ContributorBreakout Stocks Of The Week...
- ContributorFast Money's Overlooked Bio...
- ProBuffalo Small Cap (BUFSX)
Latest AMLN Headlines from TheStreet
- Amylin Pharmaceuticals Inc Stock Downgraded (AMLN) 02.09.12 | 06:02 am
- Analysts' Actions: IBM, AON, FOSL, HUM, EMC 02.07.12 | 09:02 am
- Amylin Pharmaceuticals' CEO Discusses Q4 2011 Results - Earnings Call Transcript 02.06.12 | 08:02 pm
- The Curse of Amylin's Diabetes Drug Approval 02.06.12 | 08:02 am
- Amylin Pharmaceuticals Inc Stock Upgraded (AMLN) 02.03.12 | 05:02 am
- 8 Stocks Rising on Monster Volume 01.30.12 | 03:01 pm
- PharMerica, Amylin: After-Hours Trading 01.27.12 | 06:01 pm
- Third Time's The Charm for Approval of Amylin Diabetes Drug 01.27.12 | 03:01 pm
- Firing Line: Top Gun Options Trades AMLN 01.23.12 | 10:01 am
- Friday's Top 10 Articles, Videos on TheStreet 01.20.12 | 02:01 pm
Press Releases for AMLN
- Amylin Pharmaceuticals To Present At The Leerink Swann 2012 Global Healthcare Conference - PR Newswire 02.09.12 | 04:02 pm
- Amylin Pharmaceuticals To Webcast 2011 Year-End Financial Results - PR Newswire 01.30.12 | 04:01 pm
- Amylin Outlines Corporate Strategy To Maximize Global Value Of Diabetes Franchise And Advance Key Pipeline Candidates - PR Newswire 01.09.12 | 05:01 pm
- Amylin Pharmaceuticals To Present At The 30th Annual J.P. Morgan Healthcare Conference - PR Newswire 01.03.12 | 08:01 am
- Amylin Pharmaceuticals To Present At The 23rd Annual Piper Jaffray Healthcare Conference - PR Newswire 11.23.11 | 04:11 pm
- Amylin Pharmaceuticals Announces Date And Time Change To Previously Announced Presentation At The Credit Suisse 2011 Healthcare Conference - PR Newswire 11.09.11 | 08:11 am
- Lilly And Amylin Mutually Agree To End Diabetes Alliance And Transition Exenatide Responsibility To Amylin - PR Newswire 11.08.11 | 06:11 am
- Amylin Pharmaceuticals To Present At The Credit Suisse 2011 Healthcare Conference - PR Newswire 11.02.11 | 04:11 pm
- BYETTA® Approved For Use With Insulin Glargine In The U.S. - PR Newswire 10.19.11 | 06:10 pm
- Amylin Pharmaceuticals To Webcast Third Quarter Results - PR Newswire 10.12.11 | 04:10 pm
Partner Headlines for AMLN
- Jefferies & Company Raises PT on Amylin Pharmaceuticals from $25 to $30 - Benzinga 02.07.12 | 09:02 am
- Novo Nordisk Posts Solid 4Q - Analyst Blog - Zacks 02.06.12 | 10:02 am
- The Zacks Analyst Blog Highlights: Alkermes plc, Elan, Johnson & Johnson, Amylin Pharmaceuticals and Eli Lilly & Company - Press Releases - Zacks 02.06.12 | 09:02 am
- Amylin Pharmaceuticals Continues to Soar in Wake of Bydureon Approval - Benzinga 02.02.12 | 01:02 pm
- Company News for January 31, 2012 - Corporate Summary - Zacks 01.31.12 | 10:01 am
- Billionaire Carl Icahn's Top Stock Picks And Portfolio Activity - Seeking Alpha 11.23.11 | 08:11 am
- Company News for November 15, 2011 - Corporate Summary - Zacks 11.15.11 | 10:11 am
- 6 Biotechs That Could See Huge Gains (Like Inhibitex) - Seeking Alpha 11.11.11 | 09:11 am
- Company News for November 9, 2011 - Corporate Summary - Zacks 11.09.11 | 10:11 am
- 11 Stocks Carl Icahn And Jim Simons Are Bullish On - Seeking Alpha 09.18.11 | 09:09 am
